Analytical Data
-
Gene name
RAB33B
- Application
-
Species
Human
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9H082
-
Expression Region
1-229aa
-
Molecular Weight
31.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RAB33B is a member of the RAS oncogene family, specifically belonging to the RAB subfamily of small GTPases, which are crucial in regulating intracellular vesicle trafficking and membrane dynamics. It is primarily expressed in various human tissues and plays significant roles in cellular processes such as autophagy, secretion, and endocytosis. Research has indicated that RAB33B is involved in several physiological and pathological processes, including neuronal functions and potentially in the progression of cancers. Given its significant role in cellular trafficking, the study of RAB33B has gained attention in the context of understanding the molecular mechanisms underlying various diseases. Recombinant RAB33B protein has been produced for in vitro studies, enabling researchers to investigate its functional properties, binding interactions, and the impact of its mutations. This foundational knowledge enhances our understanding of its role in cell biology and provides insights into potential therapeutic targets for diseases associated with dysfunctional cellular trafficking. As such, research on RAB33B and its recombinant protein not only contributes to the basic understanding of cellular mechanisms but also holds promise for future biomedical applications.
